v3.26.1
Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Preferred shares
Ordinary shares
Additional paid-in capital
Receivables on account of shares
Accumulated deficit
Total
Balance at Dec. 31, 2022 $ 248 $ 2,021 $ (2,921) $ (900)
Balance (in Shares) at Dec. 31, 2022 [1] 70 870        
Issuance of shares (see Note 8a5) 506 (196) 310
Issuance of shares (see Note 8a5) (in Shares) [1]   302        
Conversion of convertible note into shares (see Note 8a4) 899 899
Conversion of convertible note into shares (see Note 8a4) (in Shares) [1]   529        
Share based payment 100 100
Net loss (600) (600)
Balance at Dec. 31, 2023 $ 248 3,526 (196) (3,521) (191)
Balance (in Shares) at Dec. 31, 2023 [1] 70 1,701        
Issuance of shares (see Note 8a5) 70 196 266
Issuance of shares (see Note 8a5) (in Shares) [1]   41        
Reclassification of warrant liability to equity (see Note 10) 316   316
Conversion of preferred shares into ordinary shares (see note 7) $ (248) 248 248
Conversion of preferred shares into ordinary shares (see note 7) (in Shares) [1] (70) 70        
Issuance of shares and warrants under initial public offering, net (see note 1d) 2,916 2,916
Issuance of shares and warrants under initial public offering, net (see note 1d) (in Shares) [1]   639        
Conversion of convertible note into shares (see Note 8a4) 225 225
Conversion of convertible note into shares (see Note 8a4) (in Shares) [1]   132        
Issuance of shares in connection with patent license agreement (see Note 8a6)     3,000 3,000
Issuance of shares in connection with patent license agreement (see Note 8a6) (in Shares) [1]   213        
Share based payment     51 51
Net loss (1,545) (1,545)
Balance at Dec. 31, 2024 10,352 (5,066) 5,286
Balance (in Shares) at Dec. 31, 2024 [1]   2,796        
Share based payment   1,310   1,310
Share based payment (in Shares) [1]   43,333        
Issuance of shares, warrants and pre-funded warrants, net (see Note 8)   6,489   6,489
Issuance of shares, warrants and pre-funded warrants, net (see Note 8) (in Shares) [1]   554,234        
Exercise of warrants and pre-funded warrants (see Note 8)     11,244   11,244
Exercise of warrants and pre-funded warrants (see Note 8) (in Shares) [1]   993,869        
Issuance of shares (RSU)    
Issuance of shares (RSU) (in Shares) [1]   14,034        
Net loss     (3,335) (3,335)
Balance at Dec. 31, 2025   $ 29,395   $ (8,401) $ 20,994
Balance (in Shares) at Dec. 31, 2025 [1]   1,608,266        
[1] After giving effect to the share splits and the reverse share splits, see also note 8.